Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOCILIZUMAB”

432 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 432 results

Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Post-approval studies (Phase 4)Study completedNCT01010503
What this trial is testing

Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 32
Large-scale testing (Phase 3)Study completedNCT00773461
What this trial is testing

Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 209
Large-scale testing (Phase 3)Study completedNCT04356937
What this trial is testing

Efficacy of Tocilizumab on Patients With COVID-19

Who this might be right for
SARS-CoV 2
Massachusetts General Hospital 243
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT03867617
What this trial is testing

Cell Therapy for Immunomodulation in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Thomas Wekerle 12
Not applicableStudy completedNCT05394909
What this trial is testing

Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients

Who this might be right for
GCATOCILIZUMABGlucocorticoids+1 more
Azienda USL Reggio Emilia - IRCCS 20
Not applicableStudy completedNCT01669902
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Early research (Phase 1)Study completedNCT06262477
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants

Who this might be right for
Healthy Volunteer
Biogen 300
Post-approval studies (Phase 4)Ended earlyNCT01661140
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 427
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Post-approval studies (Phase 4)Looking for participantsNCT06927375
What this trial is testing

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing

Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58
Not applicableStudy completedNCT01392001
What this trial is testing

An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 322
Testing effectiveness (Phase 2)UnknownNCT04332094
What this trial is testing

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

Who this might be right for
COVID-19
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 276
Testing effectiveness (Phase 2)Ended earlyNCT03554161
What this trial is testing

Tocilizumab for the Treatment of Refractory Behcet's Uveitis

Who this might be right for
Behcet SyndromeUveitis
Wenjie Zheng 3
Large-scale testing (Phase 3)Looking for participantsNCT06818266
What this trial is testing

Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseAcute Chest Syndrome
Assistance Publique - Hôpitaux de Paris 130
Testing effectiveness (Phase 2)Study completedNCT04871854
What this trial is testing

Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints

Who this might be right for
Breast Cancer
Beni-Suef University 100
Next Page